trial

Creating Live Interactions to Mitigate Barriers

NCTId NCT03317769
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 31 (actual)
Sponsored by Posit Science Corporation
Primary completion 2019-05-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
31 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2018-04-01
Primary completion
2019-05-31
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Computerized plasticity-based adaptive cognitive trainingCommercially available computerized trainingOptimized social skills trainingUnstructured support group sessions

Sponsors

Posit Science CorporationLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Bruno Biagianti, MD, PhDPrincipal Investigator

Sites

1 total
San Francisco, United States

Facts & assertions

4 sourced
Enrollment
31
Phase
NA
Primary Completion Date
2019-05-31
Status
COMPLETED
relationships
The graph out of here
drug
Computerized plasticity-based adaptive cognitive training
drug
Commercially available computerized training
drug
Optimized social skills training
drug
Unstructured support group sessions
drug
lead_sponsor
Posit Science Corporation
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Bruno Biagianti, MD, PhD
person